Pharma Lobbying Spelled Demise For Rx Pricing Policy In Budget Deal

By Rachel Cohrs / July 22, 2019 at 7:14 PM
Lobbying by the pharmaceutical industry and lawmakers' desire to move new policy through regular order killed the White House’s request to attach $115 billion in drug-pricing offsets to a budget caps deal, a top aide to House Speaker Nancy Pelosi (D-CA) said Monday (July 22). Sources said last week that the White House likely requested policies be included that would make drug makers pay back Medicare for price hikes higher than inflation and raise the rebate cap in Medicaid. Wendell...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.